At this year’s American Association for Cancer Research® (AACR) Annual Meeting 2026 in San Diego on April 17-22, Biognosys Group will have a strong presence with 8 scientific posters and an immersive booth experience.
We are excited to meet you at our poster presentations and booth #2351.
Presenter: Matthijs de Geus
Date and time: Sunday, April 19, 2:00 PM – 5:00 PM
Session Category: Bioinformatics / Computational Biology / Systems Biology / Convergent Science
Session Title: Liquid Biopsy: Multi-Analyte and Multi-Omic
Poster Section: 5
Poster Board Number: 13
Published Abstract Number: 106
Presenter: Erik Baier
Date and time: Monday, April 20, 9:00 AM – 12:00 PM
Session Category: Experimental and Molecular Therapeutics
Session Title: Engineering the Next Wave of Antibody-Based Cancer Therapeutics
Poster Section: 15
Poster Board Number: 13
Published Abstract Number: 1768
Presenter: Ben Chebel
Date and time: Monday, April 20, 9:00 AM – 12:00 PM
Session Category: Clinical Research
Session Title: Biomarkers Predictive of Therapeutic Benefit 3
Poster Section: 40
Poster Board Number: 8
Published Abstract Number: 2438
Presenter: Issa Isaac
Date and time: Monday, April 20, 9:00 AM – 12:00 PM
Session Category: Chemistry
Session Title: Structural and Chemical Biology
Poster Section: 39
Poster Board Number: 6
Published Abstract Number: 2417
Presenter: Christian Cizek
Date and time: Tuesday, April 21, 9:00 AM – 12:00 PM
Session Category: Immunology
Session Title: Adaptive Immunity in Cancer
Poster Section: 6
Poster Board Number: 29
Published Abstract Number: 4261
Presenter: Lida Vadakumchery
Date and time: Tuesday, April 21, 2:00 PM – 5:00 PM
Session Category: Experimental and Molecular Therapeutics
Session Title: Molecular Targets 2
Poster Section: 13
Poster Board Number: 18
Published Abstract Number: 5729
Presenter: Cameron Ellis
Date and time: Wednesday, April 22, 9:00 AM – 12:00 PM
Session Category: Chemistry
Session Title: Multi-Omics, Systems Biology, and Biological Mass Spectrometry
Poster Section: 38
Poster Board Number: 17
Published Abstract Number: 7663
Presenter: Stephen Dearth
Date and time: Wednesday, April 22, 9:00 AM – 12:00 PM
Session Category: Chemistry
Session Title: Biomarker Discovery and Signaling Networks
Poster Section: 39
Poster Board Number: 22
Published Abstract Number: 7698
Our team of experts is looking forward to greeting you at booth #2351 and discussing with you the latest on our solutions for oncology research.
Exhibit Dates and Times
Book an on-site meeting with one of our experts to explore how we could address your research needs.
TrueDiscovery is the only platform that searches the complete proteome to quantify thousands of the most relevant proteins, including an unlimited number of proteoforms. [...]
The Biognosys TrueSignature platform provides customizable proteomics panels for pharmacodynamic readouts and clinical biomarker monitoring with exceptional precision.
TrueTarget is a platform that uniquely addresses the most pressing challenges in early drug discovery by identifying on- and off-targets to accelerate and de-risk drug de [...]
The BeatBox is a fast and easy to use instrument for up to 96 samples, which completes the homogenization in as little as 10 minutes without sample cross contamination an [...]
The integration of Biognosys’ P2 single particle technology with PreOmics’ proven iST workflow introduces a next-generation, particle-based enrichment solution that i [...]
MxP Quant 1000 delivers groundbreaking coverage of biomarkers in a single kit, setting a new standard of excellence for in quantitative metabolomics profiling. High analy [...]
Biognosys AG
Wagistrasse 21
8952 Schlieren
Switzerland
Phone: +41 44 244 50 00
US Offices
Biognosys Inc
70 Bridge St, Suite 104
Newton, MA 02458
United States
